Table 4.

Self-reported Morbidities in the Past 3 Months Among Anti-HEV Seroconverters and Nonseroconverters Between Baseline and 12 Months of Follow-up, Bangladesh, 2003–2005

Symptom	Nonseroconverters (n = 746)		Seroconverters (n = 49)
	No.	%	No.	%
Anorexia	307	41.2	21	42.9
Nausea/vomiting	209	28.0	15	30.6
Severe weakness	208	27.9	18	36.7
Yellow eyes/skin*	38	5.1	6	12.2
Fever	274	36.7	13	26.5
Clay-colored stools	49	6.6	1	2.0
Dark urine	57	7.6	4	8.2
Upper right quadrant/liver pain	206	27.6	18	36.7

Abbreviation: anti-HEV, antibody to hepatitis E virus.

* P < 0.05 (χ² test for differences between groups).